Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Don't Drink the cool aid
View:
Post by suitman87 on Feb 28, 2017 12:35am

Don't Drink the cool aid

-i don't want to spam this forum, but i just wanted to point out how misinformed some of these geniuses basing this stock are

-one poster suggested that Valeant is a much better investment than concordia. suggesting that concordia will fail, fall into the abyss while valeant will gobble up the rest of the market

-valeant has 30 BILLION DOLLARS IN DEBT, has fallen from $300 in value to $21 in value in less than 2 years. it is also looking into having to sell off its assests and do major divestments in order to pay off its debt (an consider how much of that will just go to interest)

-concordia has only 4 billion dolalrs in debt, has paid off around 100 million of that in pure cash a few weeks ago with no need for any sort of divestment. it also has spent millions of dollars on research to develop new medicines. on top of this the company has an estimated 1 billion dollars in assets while its market cap is only around 100 million (the definition of undervalued) if you people legitmately think concordia can go bankrupt with 4 billion of debt with some of it already have been paid off. Valeants prospects should be burreid next to the earths core.

But what do i see when i look for news on valeant? "wait to buy this stock", "worth much more than current valuation" "price target over 30 dolalrs" SCAMS SCAMS SCAMS. these anayslists are deluded. concordia is "worth much more than the current valuation" concorida is!
Comment by NOIRISH on Feb 28, 2017 12:57am
Concordia did not pay down any of their debt.  Zero.  Zilch.  Nothing.  The payment they made last month was an earnout payment.  Learn the difference between an earnout and a debt payment before you give others on this bullboard advice. Concordia is beyond distressed and that is why their bonds are trading at over 30% yield.  If you don't think bankruptcy is in ...more  
Comment by suitman87 on Feb 28, 2017 1:43am
Norish, is a earnout not a debt? it was their final payment and thus the company is no longer in "debt" to civen. we are comparing stones and rocks here, don't focus on the irrelavent. Also as far as "debts vs assets" go concordia is certainly doing much better than many other companies in its feild. Vaient is negative billions of dollars in debt by your calculation in fact ...more  
Comment by MrHulot on Feb 28, 2017 1:56am
Suitman, Nebbish is not a weak-kneed investor. He’s a hardcore cockroach shorter.
Comment by suitman87 on Feb 28, 2017 2:18am
exactly and it seems as though he wants us all to fall into line and sell sell sell, so he can buy buy buy. it really all is a joke how dumb he thinks we are.
Comment by Stephanovich on Feb 28, 2017 7:43am
Well said Suitman87 Nice research
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities